Accu Reference Medical Lab, LLC

Accu Reference Medical Lab, LLC was paid $183.01M by Medicaid between Jan 2018 and Dec 2024, across 452 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 16% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#4 of 122

Median peer was paid$1.29M

This provider vs. median142×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,648,525	$17.48M
2019	1,783,738	$22.17M
2020	1,097,771	$24.83M
2021	1,748,125	$35.29M
2022	1,920,952	$31.49M
2023	1,997,262	$26.31M
2024incomplete	1,820,284	$25.43M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	16%	484,790	288,108	$29.64M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	12%	230,633	136,443	$22.47M
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	6.6%	266,851	155,063	$12.06M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	6.5%	467,370	276,891	$11.90M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	6.2%	131,414	97,354	$11.28M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	3.6%	110,101	73,835	$6.57M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.2%	371,184	226,480	$5.88M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.4%	296,112	260,869	$4.46M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.1%	104,131	68,413	$3.76M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.6%	20,873	17,170	$3.01M
80061	Lipid panel	1.4%	398,600	358,735	$2.54M
84443	Thyroid stimulating hormone (TSH)	1.2%	300,841	269,830	$2.28M

440 more codes

80050	General health panel	1.2%	145,313	$2.21M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.1%	115,619	$1.96M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.0%	115,635	$1.90M
80053	Comprehensive metabolic panel	1.0%	374,798	$1.86M
86769		<1%	53,684	$1.80M
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	50,456	$1.75M
87481		<1%	83,153	$1.74M
87631		<1%	41,848	$1.64M
83036	Hemoglobin; glycosylated (A1C)	<1%	339,080	$1.59M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	419,202	$1.57M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	115,584	$1.55M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	27,475	$1.44M
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	109,585	$1.37M
82607		<1%	177,974	$1.30M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	77,843	$991K
84439		<1%	216,162	$971K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	40,123	$954K
82746		<1%	129,072	$875K
87486		<1%	60,862	$866K
87581		<1%	60,760	$854K
86803		<1%	125,566	$837K
86003		<1%	15,211	$679K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	19,050	$618K
87640		<1%	42,914	$587K
87340		<1%	118,748	$575K
81514		<1%	14,711	$573K
87653		<1%	43,760	$565K
86480		<1%	16,475	$556K
84403		<1%	38,658	$520K
86708		<1%	84,714	$491K
86704		<1%	89,787	$488K
80373		<1%	56,412	$484K
80299		<1%	37,002	$480K
86696		<1%	46,687	$473K
87999		<1%	3,621	$467K
84480		<1%	85,396	$465K
87529		<1%	17,189	$454K
86706		<1%	96,882	$447K
86481		<1%	10,678	$443K
87634		<1%	17,519	$431K
80171		<1%	37,481	$423K
87799		<1%	38,264	$415K
36415	Collection of venous blood by venipuncture	<1%	348,143	$394K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	29,007	$391K
87541		<1%	26,833	$383K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	38,906	$380K
84153		<1%	44,073	$379K
80369		<1%	51,970	$377K
80347		<1%	60,142	$366K
80336		<1%	59,744	$361K
87522	Neg quan hep c or qual rna	<1%	15,795	$330K
87512		<1%	17,979	$329K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	30,820	$329K
80361		<1%	55,208	$328K
80366		<1%	34,307	$327K
84402		<1%	25,793	$327K
84481		<1%	42,558	$325K
86592		<1%	141,228	$324K
87086	Culture, bacterial; quantitative colony count, urine	<1%	77,769	$323K
82728		<1%	50,190	$320K
81001		<1%	217,568	$314K
80368		<1%	38,815	$314K
80353		<1%	64,928	$310K
80323		<1%	42,311	$309K
80363		<1%	45,473	$296K
80321		<1%	53,763	$292K
80365		<1%	56,984	$291K
86695		<1%	40,988	$290K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	20,390	$289K
80320		<1%	35,562	$286K
84702		<1%	47,258	$286K
83550		<1%	78,072	$286K
80351		<1%	50,994	$280K
80371		<1%	50,118	$277K
83789		<1%	79,090	$275K
84270		<1%	26,724	$271K
83540		<1%	97,326	$268K
80358		<1%	57,102	$267K
84146		<1%	26,930	$266K
80360		<1%	56,409	$265K
87505		<1%	5,336	$259K
86235		<1%	7,338	$252K
80359		<1%	53,050	$243K
80324		<1%	44,259	$238K
82670		<1%	17,500	$234K
83001		<1%	24,505	$232K
86762		<1%	30,018	$229K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	8,110	$228K
87507		<1%	1,393	$224K
83002		<1%	24,843	$224K
86038		<1%	41,554	$222K
83992		<1%	54,494	$214K
84144		<1%	19,804	$200K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,441	$194K
83735		<1%	59,879	$184K
86376		<1%	23,465	$176K
80345		<1%	48,457	$174K
87070		<1%	34,585	$170K
83013		<1%	5,007	$166K
82652		<1%	10,472	$165K
87536		<1%	3,317	$155K
82570		<1%	78,103	$154K
84445		<1%	6,064	$150K
84550		<1%	73,322	$150K
83655		<1%	24,653	$149K
84154		<1%	17,913	$144K
83970		<1%	8,007	$144K
87503		<1%	16,015	$141K
82627		<1%	13,456	$141K
82043		<1%	51,019	$140K
82677		<1%	11,460	$135K
80048	Basic metabolic panel (calcium, ionized)	<1%	31,647	$134K
0223U		<1%	566	$131K
80074		<1%	8,010	$128K
87563		<1%	11,364	$128K
86618		<1%	12,007	$128K
83021		<1%	12,436	$126K
87150		<1%	1,883	$124K
81226		<1%	1,764	$120K
86665		<1%	7,314	$117K
86360		<1%	2,720	$111K
86765		<1%	16,228	$107K
86800		<1%	13,263	$105K
87077		<1%	21,595	$105K
82785		<1%	12,621	$104K
86140		<1%	45,074	$104K
86787		<1%	19,681	$104K
86431		<1%	38,345	$103K
84436		<1%	86,562	$102K
87652		<1%	5,240	$102K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,611	$102K
80076		<1%	27,142	$100K
85651		<1%	61,769	$97K
87511		<1%	7,620	$96K
83516		<1%	14,444	$94K
87500		<1%	8,166	$93K
86780		<1%	13,599	$91K
84207		<1%	5,276	$88K
86357		<1%	2,643	$85K
82248		<1%	36,933	$85K
86355		<1%	2,586	$84K
83090		<1%	11,641	$84K
80164		<1%	10,445	$84K
86359		<1%	2,701	$82K
86617		<1%	5,804	$82K
86735		<1%	16,068	$80K
83880		<1%	5,186	$77K
82533		<1%	10,704	$77K
86703		<1%	12,490	$77K
83525		<1%	14,210	$77K
88142		<1%	7,096	$77K
82951		<1%	10,584	$77K
81225		<1%	1,748	$76K
80355		<1%	17,393	$74K
86060		<1%	23,137	$74K
86141		<1%	13,235	$71K
86317		<1%	7,234	$70K
80346		<1%	55,550	$67K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	21,185	$67K
87902		<1%	636	$67K
86225		<1%	12,283	$66K
84425		<1%	6,233	$65K
87498		<1%	5,408	$64K
84100		<1%	31,676	$64K
81401		<1%	1,653	$63K
84479		<1%	71,377	$62K
81241		<1%	1,116	$62K
85045		<1%	29,810	$61K
87186		<1%	16,546	$61K
82378		<1%	7,855	$60K
85027		<1%	17,271	$58K
86677		<1%	9,418	$58K
84482		<1%	7,462	$58K
82105		<1%	10,109	$57K
80354		<1%	17,751	$57K
87184		<1%	12,069	$55K
86664		<1%	6,943	$54K
82150		<1%	17,268	$51K
80348		<1%	19,109	$51K
86008		<1%	3,144	$50K
86039		<1%	9,333	$50K
81240		<1%	1,090	$50K
80362		<1%	69,916	$49K
83721		<1%	15,105	$48K
86200		<1%	6,894	$48K
86304		<1%	5,930	$48K
80364		<1%	15,264	$47K
86663		<1%	6,978	$46K
81227		<1%	1,816	$46K
83690		<1%	15,081	$45K
85610		<1%	27,555	$45K
80370		<1%	14,895	$44K
80356		<1%	11,915	$44K
80372		<1%	11,417	$43K
87625		<1%	5,544	$43K
80325		<1%	14,510	$43K
86160		<1%	3,613	$42K
81479	Unlisted molecular pathology procedure	<1%	1,911	$41K
86886		<1%	14,337	$40K
86705		<1%	13,643	$40K
82977		<1%	16,906	$40K
80335		<1%	56,150	$39K
85730		<1%	15,906	$35K
86709		<1%	12,043	$35K
86901		<1%	21,307	$35K
82784		<1%	6,368	$34K
86900		<1%	21,347	$34K
84378		<1%	6,137	$34K
86301		<1%	4,102	$34K
84466		<1%	8,717	$33K
86300		<1%	2,022	$32K
82550		<1%	11,613	$32K
87081		<1%	7,899	$30K
82672		<1%	3,125	$30K
87517		<1%	1,407	$30K
86255		<1%	6,362	$28K
84630		<1%	6,336	$28K
83003		<1%	2,571	$26K
83020		<1%	4,390	$26K
86644		<1%	3,830	$26K
83615		<1%	11,929	$25K
87350		<1%	4,498	$25K
84681		<1%	2,362	$25K
87400		<1%	1,879	$25K
86707		<1%	4,453	$24K
82180		<1%	5,071	$24K
86336		<1%	2,756	$24K
84590		<1%	4,901	$23K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,260	$23K
84446		<1%	3,346	$22K
86645		<1%	3,668	$22K
84252		<1%	2,634	$21K
82947		<1%	15,333	$21K
80178		<1%	4,648	$21K
83704		<1%	2,602	$19K
84305		<1%	2,449	$19K
87506		<1%	246	$18K
81355		<1%	1,153	$18K
88112		<1%	1,030	$18K
86615		<1%	2,340	$18K
83825		<1%	2,975	$18K
84255		<1%	1,977	$17K
81511		<1%	816	$17K
86146		<1%	805	$17K
80349		<1%	5,647	$17K
81374		<1%	1,241	$16K
83921		<1%	2,069	$16K
84703		<1%	3,901	$16K
82175		<1%	2,325	$16K
82274		<1%	3,714	$16K
82465		<1%	7,396	$16K
84260		<1%	1,831	$16K
82172		<1%	2,395	$15K
81400		<1%	1,099	$14K
82024		<1%	743	$14K
84432		<1%	2,115	$13K
84140		<1%	1,530	$13K
87209		<1%	1,807	$13K
82565		<1%	4,474	$13K
87205		<1%	5,540	$12K
86753		<1%	1,317	$12K
82679		<1%	1,156	$12K
80367		<1%	1,975	$11K
82553		<1%	2,757	$11K
86738		<1%	1,315	$11K
82542		<1%	2,404	$11K
85048		<1%	16,711	$11K
82525		<1%	2,097	$10K
80305		<1%	1,447	$10K
83520		<1%	1,950	$10K
82626		<1%	865	$9K
82664		<1%	543	$9K
86778		<1%	1,164	$9K
86666		<1%	939	$9K
87338		<1%	1,591	$8K
82530		<1%	1,275	$8K
86147		<1%	601	$8K
84450		<1%	4,051	$8K
87177		<1%	1,780	$8K
86790		<1%	944	$7K
80177		<1%	1,525	$7K
83695		<1%	2,194	$7K
81005		<1%	6,285	$7K
82397		<1%	1,587	$7K
86316		<1%	1,024	$7K
81291		<1%	1,893	$7K
84460		<1%	3,839	$7K
85379		<1%	1,351	$7K
83498		<1%	730	$7K
87045		<1%	1,276	$7K
82310		<1%	2,935	$6K
86747		<1%	705	$6K
84165		<1%	1,729	$6K
84156		<1%	5,141	$6K
86631		<1%	1,149	$6K
82642		<1%	751	$6K
83986		<1%	5,269	$6K
86593		<1%	2,357	$6K
86308		<1%	2,043	$5K
84134		<1%	1,634	$5K
84442		<1%	1,173	$5K
84484		<1%	998	$5K
87210		<1%	1,555	$5K
86702		<1%	1,196	$5K
81003		<1%	9,111	$4K
88141		<1%	424	$4K
86609		<1%	901	$4K
83521		<1%	778	$4K
82164		<1%	678	$4K
82952		<1%	1,024	$4K
88342		<1%	67	$4K
86611		<1%	286	$4K
86215		<1%	811	$3K
88341		<1%	51	$3K
86701		<1%	1,478	$3K
82108		<1%	621	$3K
82985		<1%	894	$3K
85660		<1%	1,488	$3K
83088		<1%	337	$3K
84591		<1%	1,991	$3K
87641		<1%	267	$3K
80159		<1%	844	$3K
82077		<1%	1,515	$3K
86632		<1%	803	$3K
80069		<1%	908	$3K
88312		<1%	88	$2K
86757		<1%	432	$2K
82157		<1%	171	$2K
84600		<1%	378	$2K
86658		<1%	115	$2K
86382		<1%	441	$2K
87807		<1%	142	$2K
81231		<1%	207	$2K
86671		<1%	346	$2K
87255		<1%	267	$2K
84166		<1%	323	$2K
87147		<1%	751	$2K
81230		<1%	205	$2K
85060		<1%	398	$2K
84132		<1%	1,024	$2K
82941		<1%	176	$2K
80185		<1%	274	$2K
86340		<1%	274	$2K
82166		<1%	312	$2K
87427		<1%	149	$2K
80503		<1%	567	$2K
83701		<1%	142	$2K
86037		<1%	521	$2K
80156		<1%	210	$2K
82380		<1%	469	$2K
82270		<1%	1,049	$1K
81329		<1%	70	$1K
86162		<1%	178	$1K
82668		<1%	261	$1K
87449		<1%	242	$1K
82330		<1%	389	$1K
85018		<1%	1,126	$1K
83527		<1%	326	$1K
83718		<1%	523	$1K
82747		<1%	185	$1K
85014		<1%	1,080	$1K
83010		<1%	244	$1K
84588		<1%	116	$1K
87109		<1%	195	$1K
82040		<1%	1,118	$1K
88262		<1%	16	$1K
84075		<1%	1,014	$1K
84478		<1%	830	$1K
88230		<1%	16	$994.56
82088		<1%	37	$941.92
87101		<1%	315	$930.53
87254		<1%	44	$895.70
82610		<1%	191	$791.25
86334		<1%	82	$742.32
85007		<1%	3,186	$736.67
82140		<1%	222	$717.46
84155		<1%	923	$691.03
83874		<1%	163	$679.86
82978		<1%	151	$626.56
82950		<1%	129	$610.14
86015		<1%	433	$598.35
87046		<1%	89	$596.72
81508		<1%	177	$572.44
99072		<1%	8,047	$556.92
87341		<1%	130	$508.29
84080		<1%	89	$438.19
86021		<1%	72	$426.60
83519		<1%	63	$396.56
84520		<1%	351	$367.24
80175		<1%	135	$350.46
88304		<1%	25	$326.06
81015		<1%	1,212	$322.90
87476		<1%	14	$311.73
86256		<1%	61	$307.76
82390		<1%	95	$287.00
80051		<1%	226	$276.36
86638		<1%	36	$262.88
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	57	$256.65
86341		<1%	26	$255.76
84597		<1%	26	$243.68
82495		<1%	29	$242.89
87324		<1%	38	$236.82
87168		<1%	207	$227.49
85384		<1%	56	$227.26
86692		<1%	15	$221.92
86381		<1%	56	$211.61
85004		<1%	72	$202.67
86335		<1%	14	$202.51
87480		<1%	18	$184.09
86682		<1%	13	$161.46
81328		<1%	26	$158.05
82239		<1%	16	$147.27
85613		<1%	28	$137.59
80375		<1%	996	$136.80
84202		<1%	13	$130.42
80183		<1%	41	$128.27
82300		<1%	14	$121.04
87478		<1%	14	$116.57
82955		<1%	34	$110.42
82247		<1%	88	$100.60
87040		<1%	12	$96.84
86148		<1%	12	$76.34
86036		<1%	28	$73.70
87088		<1%	25	$70.69
87329		<1%	13	$69.47
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	223	$63.32
85049		<1%	14	$51.17
82436		<1%	14	$49.28
84300		<1%	15	$42.18
84133		<1%	15	$38.39
82085		<1%	15	$25.91
82374		<1%	38	$23.09
88311		<1%	22	$22.37
99080		0%	135	$0.00
3046F		0%	13	$0.00
84295		0%	22	$0.00
83896		0%	5,521	$0.00
82435		0%	22	$0.00
80350		0%	16	$0.00
CLS34		0%	167	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBAGLEY, LUZ (CCO)